| TOTAL | $43M |
| FUNDING TOTAL | $43M |
| Series B, 5/10 MPM Capital SR One Novo Ventures Thomas, McNerney & Partners | $43M |
NeuroTherapeutics Pharma, Inc., a biopharmaceutical company, develops therapeutics for patients suffering from central nervous system disorders. It focuses on epilepsy, neuropathic, and acute pain disorders of the nervous system. The company was incorporated in 2006 and is based in Chicago, Illinois.
